41B

1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl]pyridin-2(1H)-one

Created:	2015-01-08
Last modified:	2015-09-16

Find Related PDB Entry
1 entries where 41B is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	1
Bond Count	56
Aromatic Bond Count	12

2D diagram of 41B

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl]pyridin-2(1H)-one
Systematic Name (OpenEye OEToolkits)	1-[(1S)-1-(4-chloranyl-3-fluoranyl-phenyl)-2-oxidanyl-ethyl]-4-[2-(oxan-4-ylamino)pyrimidin-4-yl]pyridin-2-one
Formula	C₂₂ H₂₂ Cl F N₄ O₃
Molecular Weight	444.886
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1ccc(cc1F)C(N2C(=O)C=C(C=C2)c3nc(ncc3)NC4CCOCC4)CO
SMILES	CACTVS	3.385	OC[CH](N1C=CC(=CC1=O)c2ccnc(NC3CCOCC3)n2)c4ccc(Cl)c(F)c4
SMILES	OpenEye OEToolkits	1.9.2	c1cc(c(cc1C(CO)N2C=CC(=CC2=O)c3ccnc(n3)NC4CCOCC4)F)Cl
Canonical SMILES	CACTVS	3.385	OC[C@@H](N1C=CC(=CC1=O)c2ccnc(NC3CCOCC3)n2)c4ccc(Cl)c(F)c4
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1cc(c(cc1[C@@H](CO)N2C=CC(=CC2=O)c3ccnc(n3)NC4CCOCC4)F)Cl
InChI	InChI	1.03	InChI=1S/C22H22ClFN4O3/c23-17-2-1-15(11-18(17)24)20(13-29)28-8-4-14(12-21(28)30)19-3-7-25-22(27-19)26-16-5-9-31-10-6-16/h1-4,7-8,11-12,16,20,29H,5-6,9-10,13H2,(H,25,26,27)/t20-/m1/s1
InChIKey	InChI	1.03	PGGLRAWFUJMQBN-HXUWFJFHSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3409588
PubChem	71727133
ChEMBL	CHEMBL3409588

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.